MedWatch

Coloplast will not exit Russia, says CEO

Around 70 employees in Russia will continue working, as the medtech firm keeps operations running in the country – out of concern for people with intimate health needs, says CEO Kristian Villumsen.

Coloplast is not leaving Russia, according to CEO Kristian Villumsen | Photo: Stine Bidstrup/ERH

At present, Coloplast has no plans to exit Russia, where the medtech firm employs around 70 people. In an interview with MarketWire, CEO Kristian Villumsen explains this, saying the firm is focused on helping people with intimate health needs in the country.

However, the Russian business should not count on further investments – quite the contrary, the CEO states.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs